PELNSEPiramal Enterprises Limited· PharmaceuticalsHighNeutral
Announced Tue, 6 May · 18:20 IST

Piramal Enterprises Limited has informed the Exchange regarding Change in Auditors of the company.

Management Changes View source PDF
Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

The board of Piramal Enterprises, at its meeting on 6th May 2025, approved several key decisions. The existing Joint Statutory Auditors — Suresh Surana & Associates LLP and Bagaria & Co LLP — will complete their term at the upcoming 78th AGM, and will be replaced by N. M. Raiji & Co. and Chhajed & Doshi as new Joint Statutory Auditors for a 3-year term till the 81st AGM (2028). N. L. Bhatia & Associates has been appointed as Secretarial Auditor for 5 years. Additionally, three Independent Directors — Suhail Nathani, Anjali Bansal and Kunal Bahl — were re-appointed for a second 5-year term. Mr. Ajay Piramal will continue as Whole-time Chairman beyond turning 70 in August 2025, until March 2027. All decisions are subject to shareholder approval.

Likely market impact

This is a routine governance update — auditor rotation at the end of a term, independent director re-appointments and the promoter's continuation are all standard corporate housekeeping and unlikely to move the stock. No red flags on governance; shareholders will vote on these appointments at the next AGM.